Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.1M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
+289K
-
Total reported value, excl. options
-
$116M
-
Value change
-
+$1.79M
-
Put/Call ratio
-
0.04
-
Number of buys
-
26
-
Number of sells
-
-32
-
Price
-
$3.47
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) as of Q1 2023
75 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
of 67.1M outstanding shares and own 49.79% of the company stock.
Largest 10 shareholders include BVF INC/IL (7.61M shares), Logos Global Management LP (3.74M shares), Cormorant Asset Management, LP (3.08M shares), Paradigm Biocapital Advisors LP (2.38M shares), JANUS HENDERSON GROUP PLC (2.09M shares), Kynam Capital Management, LP (2.01M shares), Vivo Capital, LLC (1.69M shares), VANGUARD GROUP INC (1.51M shares), CITADEL ADVISORS LLC (1.23M shares), and BlackRock Inc. (996K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.